Published 20 October 2026 · Reviewed by Dr Sin Yong
Rejuran cost is set by which preparation the skin calls for, Healer, S or I, the area treated, the amount used, whether delivery is by fine needle or injector device, how the course is staged and reviewed, and whether it is combined with another treatment. Singapore's rules restrict how fees may be advertised, so no figure appears here; a written quote follows examination on Orchard Road.
Rejuran cost factors start with which preparation the skin needs, since Healer, S and I are made for different skin and cannot be swapped. The size of the field comes next: a full face, the eye area alone or one patch of scarring is quoted separately. Whether it is placed by fine needle or an injector device, and how the course is reviewed, complete the written quote.
Why is there no Rejuran figure on this page?
Singapore's rules for medical advertising restrict how doctors may publish fees, and a figure given before examination would describe a plan that does not exist. Rejuran is a polynucleotide purified from salmon DNA, registered with the Health Sciences Authority as an injectable medical device and placed into the dermis to act on how the skin repairs itself. It adds no volume, does not lift and does not remove pigment, so the first thing the assessment decides is whether it is the right product for your complaint at all. The practice-wide rules are on how fees are quoted.
Illustrative image — not a patient.
Healer, S or I: which preparation, and why does it change the fee?
The three share the same polynucleotide; what changes is viscosity and therefore where the material can sensibly be placed, and the quote names which one. Rejuran Healer is the mid-viscosity, whole-face preparation spread across a field of skin for texture, fine lines and elasticity. Rejuran S is thicker and is placed into and around scars rather than spread, as the skin-quality component of a wider acne scar plan. Rejuran I is thinner, for the fragile periorbital skin where a thicker gel would sit visibly. Rejuran HB combines polynucleotide with hyaluronic acid in one syringe for skin that needs both a repair signal and hydration.
They are not interchangeable, so a quote for the wrong one is a quote for the wrong treatment: Healer across a field of acne scars does less than S into them, and Healer under the eye sits where I would not. The preparation follows the examination, and where the skin is short of something that polynucleotide does not supply, a different class of skin booster may be quoted instead.
“Healer, S and I are the same polynucleotide at different thicknesses. A quote that does not say which one is a quote for a product, not for your skin.”
Dr Sin YongOn how Rejuran is quoted
How do the area and the amount set the quantity?
The area is the plainest driver. A full face is one line; the periorbital area alone is another; a defined field of scarred skin is a third, and a face that needs Healer across the cheeks and S into the scars carries both. The amount follows the area and the skin: a larger face, or a wider field of scarring, takes more product to cover, and the quote states the quantity for each line.
Illustrative image — not a patient.
Delivery is chosen at assessment. Rejuran is placed intradermally as a field of micro-injections, by fine needle or by an injector device, and the choice affects the consumables and the time the visit takes. Numbing is part of the visit rather than an extra, and physician time runs through every line, because Dr Sin Yong performs the injections himself.
Finding at examination
Preparation and area planned
What moves the quantity
Thin, dull or crepey facial skin
Healer across the face
Face size; whether neck is added as its own line
Fine lines and crepey skin around the eyes
Rejuran I, periorbital area
Periorbital area only, once the under-eye cause is diagnosed
Post-acne skin with scarring
S into the scars, sometimes Healer around them
Extent of the scarred field; whether both are used
A hollow, descent or pigment
Not Rejuran
A structural, lifting or light-based plan is quoted instead
How is a Rejuran course planned and reviewed?
Collagen-directed classes such as polynucleotides work gradually, so the small papules seen on the day are not the result and the effect is judged later. The plan and any interval between visits are set individually at review: an initial phase that builds the effect, then maintenance spaced further apart and timed by how the skin holds the change. No standard course is quoted; the plan is reviewed after each phase, and the review therefore appears on the quote. The consultation is a medical visit with its own fee, and where earlier filler or threads are in the area, or a laser or peel has been done recently, timing changes and what is already in the tissue may need to be established first.
What about combinations, and how should you compare quotes?
Rejuran addresses the dermal environment, and it is often planned alongside something that does a different job: RF microneedling or resurfacing for the structure of acne scars, a laser for pigment, or an energy-based lifting treatment for descent. Each is quoted as its own line, and skin boosters with RF microneedling explains which goes first and why.
Not on the quote: packages sold on the day, incentives for reviews, and any treatment the assessment does not support. When comparing with a quote from elsewhere, check which preparation is named, that it is the injectable product and not a topical salmon-DNA serum applied at a salon, that a doctor is administering it, the area and quantity, and whether review is included. Fish allergy, pregnancy and active skin infection are checked before Rejuran is offered at all, and recovery is on the skin booster aftercare page.
Your next step
1. MessageWhatsApp +65 8023 7170 with what is bothering you. A reply comes from the clinic, not a bot.
2. AssessmentDr Sin Yong examines you himself on Orchard Road, with ultrasound where earlier filler is involved.
3. A plan in writingWhat he would do, what he would not, the fee factors, and the option of no treatment.
Every treatment is performed by Dr Sin Yong personally. Singapore Medical Council registered · invited to share his clinical expertise internationally for CLASSYS, DEKA, Fotona, Hironic and Ilooda.
Mention any fish allergy and bring details of earlier injectables or scar treatment. How consultations work.
Singapore's rules restrict how fees may be advertised, so no figure is given here. The fee follows which preparation the skin calls for, Healer, S or I, the area treated, the amount used, whether delivery is by fine needle or injector device, how the course is staged and reviewed, and whether it is combined with another treatment. A written quote follows examination.
Yes, because they are planned differently. Healer is spread across the face; S is placed into and around scars in a defined field; I is placed in the periorbital area only. The quote names the preparation and the area, and the examination decides which suits, since they are not interchangeable.
No number is fixed in advance and no standard course is quoted. Plans are described as an initial phase that builds the effect and a maintenance phase spaced further apart, reviewed after each phase and timed by how the skin is holding. The written quote shows how the phases and the review are treated rather than selling a fixed course.
It is not the same thing. A salon facial applies a polynucleotide or salmon-DNA serum to the surface, sometimes after a device that creates fine channels; the injectable places the material in the dermis and in Singapore is a medical treatment performed by a doctor. Confirm the product, the preparation and who is administering it before comparing figures.
References
The Effectiveness of Polynucleotides in Esthetic Medicine: A Systematic Review. Journal of Cosmetic Dermatology (Lampridou S et al.), 2025. source
A phase III, randomized, double-blind, matched-pairs, active-controlled clinical trial and preclinical animal study to compare the durability, efficacy and safety between polynucleotide filler and hyaluronic acid filler. Journal of Korean Medical Science (Pak CS et al.), 2014. source
About this page: written and medically reviewed by Dr Sin Yong, MBBS (NUS), MRCS (Edinburgh) · Last reviewed 20 October 2026 · Illustrative images only, not patients · Editorial policy
